A certificate of analysis (COA) is a laboratory report. A COA can support the identity and amount of each ingredient in a peptide blend—but only when the testing actually measures each ingredient in the finished blend. A product name, one purity percentage, or separate reports for the starting ingredients does not establish all of that.
For a blend sold as GLOW, start with the exact ingredient list on that product. The nickname alone does not tell you the formula, chemical forms, or batch. Then ask four separate questions: what is present, how much of each is present, what impurities were assessed, and which sample was tested?
A worked example: three ingredients, three separate checks
Illustrative example only. The table below is invented to teach report reading. It is not a real COA, a product test, or a verification of a seller. Imagine a label claiming Ingredient A 20 mg, Ingredient B 5 mg and Ingredient C 5 mg: 30 mg total.
| Ingredient | What the hypothetical report says | What is still needed |
|---|---|---|
| A — label: 20 mg | Identity supported; amount reported as 19.8 mg/vial using a named quantitative method. | Method suitability, reference/calibration information, uncertainty where available, and the sample-to-batch connection. |
| B — label: 5 mg | Identity supported, but no per-vial amount reported. | A quantitative result for B. Detecting it does not establish 5 mg. |
| C — label: 5 mg | No separate identity or amount result. | Both checks. A total of 30 mg cannot fill this gap. |
The right conclusion is “some claims have supporting measurements; others remain unverified.” It is not automatically “fake,” and it is not “all three ingredients verified.” Compare any measured result with a stated specification and its measurement context rather than inventing your own pass threshold.
Why doesn’t “99% purity” settle the blend?
Ask what the percentage describes: one ingredient, combined target peaks, or a different calculation. HPLC, or high-performance liquid chromatography, separates sample components for measurement. A chromatographic area percentage describes detector response under that method; it is not automatically the mass of each ingredient in a vial.
NIST’s record of a peptide-quantification study describes content measurement using an HPLC assay against a characterized external standard. That is a useful distinction: an instrument can be used for different analytical questions, and “HPLC tested” alone does not tell you which question the reported result answers.
Does the right ratio prove the right milligrams?
No. In our invented example, the label ratio is 20:5:5, or 4:1:1. A sample containing 10 mg, 2.5 mg and 2.5 mg would have that same ratio but only half the labeled amount of each ingredient. A ratio and an amount per vial answer different questions. Keep measured values separate from values copied from the label.
Can the method distinguish all the ingredients?
A mixed sample creates opportunities for overlapping signals and interference. Ask the laboratory whether its method can identify and quantify each named component in that particular mixture—not just in a pure reference sample.
ICH Q2(R2), the analytical-validation guideline, explains that identification and quantitation must account for potential interference. It also discusses using more than one procedure when a single procedure cannot distinguish components adequately. These principles help frame questions for a laboratory; citing the guideline does not certify a particular seller or report.
Do separate ingredient COAs count?
They can document the submitted starting-material samples. They do not, by themselves, show that the finished blend contains the claimed amount of each ingredient. Mixing, filling, the tested sample and the lot connection still need documentation.
Check the original report with its issuing laboratory when possible. Match the report number, sample description, lot identifier and dates. Ask whether the laboratory received a finished blended vial or separate raw materials, and who selected the sample. One tested vial does not establish that every vial was sampled.
For a field-by-field explanation of those records, see JD BioWorks’ COA guide. This is contextual reading, not independent verification by PeptideWhy.
What the report still cannot tell you
Identity, amount and chemical-purity results are not substitutes for sterility or endotoxin tests, and none establishes that a blend benefits people. See what a COA says about sterility for the separate questions involved.
Five questions to send with a blend report
- Was the tested sample the finished blend, and how does it match this lot?
- Is there a distinct identity result for every listed ingredient?
- Is there a measured amount per ingredient, with units and a suitable quantitative method?
- What does the purity percentage describe, and how were overlapping signals handled?
- Which claims were not tested or remain unresolved?
Use the COA checklist to record the answers. Keep “not tested,” “not reported” and “failed” separate: they mean different things.
Sources reviewed November 3, 2026. Original hypothetical example; no laboratory verification or human-use recommendation is claimed.